PROVIDER PROFILE · NPI 1457603474

Kathryn NassarPA-L

PRESCRIBING · PART D · 2024
Total Rx claims
154
Beneficiaries
—
Total drug cost
$76K
Distinct drugs
4
Brand share
70.1%
Top prescribed drugs
Topiramate46 claims
Semaglutide44 claims
Metformin Hcl35 claims
Tirzepatide29 claims
QUALITY · MIPS · 2024
Final MIPS score
97.1
Quality
82.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.93%
APM Entity